Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,672
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
for
Atopic Dermatitis
Location: Marietta GA, Panama City FL, St. Petersburg FL,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07765888
Phase 3, Recruiting
New
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
for
Atopic Dermatitis
Location: Marietta GA, Memphis TN, Indianapolis IN, Tulsa OK,
Sponsor: Pfizer
Sex: All
Age: 12+
Code: NCT07783425
Phase 3, Recruiting
HPV Vaccine Reduced Dose
for
HPV
Location: Decatur GA
Sponsor: Emory University
Sex: All
Age: 18 - 45
Code: NCT06799494
Recruiting
NV PSR INSPIRE-A Pipeline™ Vantage Post Approval Study
Get alerts for new trials in your area by subscribing now
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions
for
Angina, Stable Ischemic Heart Disease
Location: Marietta GA, Durham NC, Fairfax VA, Chicago IL,
Sponsor: Yale University
Sex: All
Age: 65+
Code: NCT05786417
Recruiting
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
for
Pulmonary Disease, Chronic Obstructive
Location: Atlanta GA, Morrow GA, Adairsville GA, Knoxville TN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT06961214
Phase 3, Recruiting
H5N1 Milk Detection Study
for
Influenza
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 64
Code: NCT06850298
Recruiting
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
for
Arthritis, Psoriatic
Location: Marietta GA, Salisbury NC, Charlotte NC, Evansville IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07321873
Phase 2, Recruiting
Study of BHV-1400 in IgA Nephropathy
for
IgA Nephropathy
Location: Lawrenceville GA, Orlando FL, Indianapolis IN,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18 - 65
Code: NCT07054684
Phase 1, Recruiting
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
for
Lupus Erythematosus, Systemic
Location: Marietta GA, Charlotte NC, Jackson TN, Fayetteville NC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07438496
Phase 3, Recruiting
A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)
for
Follicular Lymphoma
Location: Marietta GA, Newnan GA, Mobile AL, Roanoke VA,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06911502
Phase 3, Recruiting
Involving Communities in Addressing the Maternal Health Crisis: Making an IMPACT
for
Preconception Health
Location: Atlanta GA
Sponsor: Morehouse School of Medicine
Sex: All
Age: 18 - 44
Code: NCT05987059
Phase 2, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
for
Atopic Dermatitis
Location: Atlanta GA, Macon GA, Birmingham AL, Louisville KY,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT06947993
Phase 2, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
for
Multiple Myeloma
Location: Atlanta GA, Charlotte NC, Winston-Salem NC,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06892522
Phase 1, Phase 2, Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: Marietta GA, Louisville KY, Germantown TN, St Louis MO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)